Q1 2025 Holdings
Filed 2025-05-15 | 21 holdings | $198.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $31.1M | 199,264 | 15.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $25.7M | 518,177 | 13.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $14.1M | 577,696 | 7.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.9M | 413,711 | 7.0% |
| Merus N V | COM | N5749R100 | $13.6M | 323,211 | 6.9% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $13.4M | 343,849 | 6.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $12.8M | 1,041,280 | 6.5% |
| Celcuity Inc(CELC) | COM | 15102K100 | $11.1M | 1,093,677 | 5.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.9M | 1,480,020 | 4.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.8M | 232,295 | 4.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $8.6M | 2,426,436 | 4.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.2M | 13,862 | 4.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $6.5M | 448,692 | 3.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $4.4M | 598,191 | 2.2% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $3.9M | 560,979 | 2.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $3.5M | 552,926 | 1.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.9M | 255,060 | 1.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $2.4M | 116,353 | 1.2% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.1M | 732,463 | 1.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.0M | 59,017 | 1.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $454.3K | 499,254 | 0.2% |